Publications by authors named "Brenda B Rush"

Claim this Profile
I
Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.
James V Lacey, Victoria M Chia, Brenda B Rush, Danny J Carreon, Douglas A Richesson

Int J Cancer· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical human papillomavirus detection forecasts cervical cancer risk in women over 18 years of follow-up.
Philip E Castle, Andrew G Glass, Brenda B Rush, David R Scott, Nicolas Wentzensen

J Clin Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.
Mark Schiffman, Andrew G Glass, Nicolas Wentzensen, Brenda B Rush, Philip E Castle

Cancer Epidemiol Biomarkers Prev· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.
James V Lacey, Mark E Sherman, Brenda B Rush, Brigitte M Ronnett, Olga B Ioffe

J Clin Oncol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
James V Lacey, George L Mutter, Marisa R Nucci, Brigitte M Ronnett, Olga B Ioffe, Brenda B Rush

Cancer· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reproducibility of biopsy diagnoses of endometrial hyperplasia: evidence supporting a simplified classification.
Mark E Sherman, Brigitte M Ronnett, Olga B Ioffe, Douglas A Richesson, Brenda B Rush

Int J Gynecol Pathol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
James V Lacey, George L Mutter, Brigitte M Ronnett, Olga B Ioffe, Máire A Duggan, Brenda B Rush

Cancer Res· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polycyclic aromatic hydrocarbon-DNA adducts in cervix of women infected with carcinogenic human papillomavirus types: an immunohistochemistry study.
M Margaret Pratt, Paul Sirajuddin, Miriam C Poirier, Mark Schiffman, Andrew G Glass, Brenda B Rush

Mutat Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus (HPV) genotyping using paired exfoliated cervicovaginal cells and paraffin-embedded tissues to highlight difficulties in attributing HPV types to specific lesions.
Patti E Gravitt, Leen Jan van Doorn, Wim Quint, Mark Schiffman, Allan Hildesheim, Brenda B Rush

J Clin Microbiol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal outcomes following cervical cancer screening: event duration and health utility loss.
Ralph P Insinga, Andrew G Glass, Evan R Myers, Brenda B Rush

Med Decis Making· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus prevalence in women who have and have not undergone hysterectomies.
Philip E Castle, Mark Schiffman, Andrew G Glass, Brenda B Rush, David R Scott

J Infect Dis· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "Use of cervical cancer screening among insured women: the extent of missed opportunities" [Health Policy 73 (2005) 194-201].
Ralph P Insinga, Andrew G Glass, Brenda B Rush

Health Policy· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
Michelle J Khan, Philip E Castle, Attila T Lorincz, Sholom Wacholder, Mark Sherman, Brenda B Rush

J Natl Cancer Inst· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semiquantitative human papillomavirus type 16 viral load and the prospective risk of cervical precancer and cancer.
Philip E Castle, Mark Schiffman, David R Scott, Mark E Sherman, Andrew G Glass, Brenda B Rush

Cancer Epidemiol Biomarkers Prev· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnoses and outcomes in cervical cancer screening: a population-based study.
Ralph P Insinga, Andrew G Glass, Brenda B Rush

Am J Obstet Gynecol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The health care costs of cervical human papillomavirus--related disease.
Ralph P Insinga, Andrew G Glass, Brenda B Rush

Am J Obstet Gynecol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pap screening in a U.S. health plan.
Ralph P Insinga, Andrew G Glass, Brenda B Rush

Cancer Epidemiol Biomarkers Prev· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer.
Philip E Castle, Attila T Lorincz, David R Scott, Mark E Sherman, Andrew G Glass, Brenda B Rush

J Clin Microbiol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis.
Mark E Sherman, Attila T Lorincz, David R Scott, Sholom Wacholder, Philip E Castle, Brenda B Rush

J Natl Cancer Inst· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute risk of a subsequent abnormal pap among oncogenic human papillomavirus DNA-positive, cytologically negative women.
Philip E Castle, Sholom Wacholder, Mark E Sherman, Attila T Lorincz, Andrew G Glass, Brenda B Rush

Cancer· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women.
Philip E Castle, Sholom Wacholder, Attila T Lorincz, David R Scott, Mark E Sherman, Brenda B Rush

J Natl Cancer Inst· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral load of human papillomavirus and risk of CIN3 or cervical cancer.
Attila T Lorincz, Philip E Castle, Mark E Sherman, David R Scott, Andrew G Glass, Brenda B Rush

Lancet· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis